The Large and Small Isoforms of Human Papillomavirus Type 16 E6 Bind to and Differentially Affect Procaspase 8 Stability and Activity

Maria Filippova, Melyssa M. Johnson, Marnelli Bautista, +5

Journal of Virology

INDUCTION OF PROTECTIVE IMMUNITY IN CHICKENS IMMUNISED WITH PLASMID DNA ENCODING INFECTIOUS BURSAL DISEASE VIRUS ANTIGENS

Nadja Fodor, Syamalima Dube, I Fodor, +4

Acta Veterinaria Hungarica

The Full-Length Isoform of Human Papillomavirus 16 E6 and Its Splice Variant E6* Bind to Different Sites on the Procaspase 8 Death Effector Domain

Sandy S. Tungteakkhun, Maria Filippova, Nadja Fodor, +1

Journal of Virology

E6 IsoformsApoptosisImmunologyHuman Papillomavirus 16Pathology +16

The Interaction between Human Papillomavirus Type 16 and FADD Is Mediated by a Novel E6 Binding Domain

Sandy S. Tungteakkhun, Maria Filippova, Jonathan W. Neidigh, +2

Journal of Virology

ApoptosisImmunologyPathologyCell DeathViral Structural Protein +15

Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses

Béla Dénes, Jie Yu, Nadja Fodor, +3

Molecular Biotechnology

VaccinationViral PersistencePathogenesisViral PathogenesisImmunology +6

Protection of NOD Mice From Type 1 Diabetes After Oral Inoculation with Vaccinia Viruses Expressing Adjuvanted Islet Autoantigens

Béla Dénes, Valentina I. Krausova, Nadja Fodor, +6

Journal of Immunotherapy

Gut MucosaeHumoral ResponseViral PathogenesisImmunologyImmunodominance +17

Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor

Béla Dénes, Daila S. Gridley, Nadja Fodor, +3

The Journal of Gene Medicine

Immunological characterisation of glycoprotein E of Aujeszky's disease virus

O. S. Morenkov, Nadja Fodor, Yuri A. Sobko, +1

Virus Research

Diagnostic VirologyMolecular VirologyAutoimmune DiseaseViral PathogenesisImmunology +4

Construction of Recombinant Vaccinia Viruses Using PUV-Inactivated Virus as a Helper

Tatyana M. Timiryasova, Bing Chen, Nadja Fodor, +1

BioTechniques

Viral ReplicationRecombinant VvsSynthetic VirologyImmunologyVaccine Target +15